Interview: Green Chemistry
“Green Chemistry – Key Driver of Sustainability in the Pharmaceutical Industry”
PROCESS: As the API-R&D department of your company is renowned for its cost-effective development of active pharmaceutical ingredients, how does your company see the role of innovation and research in today’s market scenario?
Dr. BANDICHHOR: Innovation provides distinctive advantage over others as it helps to understand the complexities involved in product development. Particularly, innovation through Green Chemistry and Engineering is bound to enable robust, scalable and safe processes. One of the essential components to derive high business value out of innovation is to collaborate and learn from global experts about dealing with problem areas based on their experiences. In essence, innovation leads to profitability and learnability that inspires further innovation and that’s how the knowledge industry grows. This is important for survival.
PROCESS: Given the fact that research is the lifeline, do you think Indian academic institutions and R&D organizations support research in a large way?
Dr. BANDICHHOR: Not only Indian academic institutions, there should be global academiaindustry collaboration to foster the needs of society through science and technology. Industry scientists can help train the trainer (teachers) so that they and their students may get aligned with the industrial way of working. It is important to have effective networking through conferences. We should focus on capability building through science and technology before we get into business trade-off.
Considering the structural complexity of the upcoming molecules, it has become more important to venture into an advanced level of research and development rather than depending upon old ways of practising science. This is where the academia industry partnership can play a pivotal role. Industry-academia collaboration at every level of drug development can help fill the existing gaps and move towards sustainability, truly based on science and technology.
PROCESS: Please share your thoughts on how R&D in Indian pharma sector could be taken more seriously in terms of investments and opportunities?
Dr. BANDICHHOR: Without innovation it would be difficult to survive in the Indian pharmaceutical industry. In order for innovation to continue, gradual huge investments are required. Such investments should aim at creation of state-of-the-art instrumentation facilities to conduct high-end research in India.
We need to train our young generation to meet future R&D challenges. Success in the pharmaceutical sector requires a high degree of innovation and fundamental understanding of ways to connect science and technology to any business. Such kind of expertise that scientists gain over a period helps them to deliver innovative products to the society. In due course, they encourage fellow colleagues to pursue strategies for strengthening the scientific acumen for profitability and uplifting the society through scientific deliberations, which would be impossible without R&D investments.